1.
Indian J Med Microbiol
;
2016 Jan-Mar; 34(1): 114
Artigo
em Inglês
| IMSEAR
| ID: sea-176567
2.
Southeast Asian J Trop Med Public Health
;
2004 Dec; 35(4): 954-8
Artigo
em Inglês
| IMSEAR
| ID: sea-33771
RESUMO
We evaluated the CR326F strain (VAQTA) derived hepatitis A vaccine in Korean children and adolescents >2 years of age to consider a future immunization program. In our study, the pediatric two-dose regimen of VAQTA was found to be generally well tolerated and resulted in 100% (95% CI 94.8, 100.0) seroconversion after 2 doses. Immunizing children with the HAV vaccine routinely should be considered in South Korea, particularly in areas where recent outbreaks have occurred.